Hagens Berman Reminds Synergy Pharmaceuticals Investors of the April 10, 2018 Lead Plaintiff Deadline and Alerts them to the Expanded Class Period
07 mars 2018 16h00 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, March 07, 2018 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) investors to the expanded class period and the April 10, 2018...
Hagens Berman Reminds Synergy Pharmaceuticals Investors of the April 10, 2018 Lead Plaintiff Deadline in the Securities Class Action Linked to Loan Disclosures
28 févr. 2018 09h30 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) of the April 10, 2018 Lead Plaintiff deadline in the...
Hagens Berman Alerts Synergy Pharmaceuticals Investors to the Securities Class Action Concerning Loan Disclosures and to the April 10, 2018 Lead Plaintiff Deadline
14 févr. 2018 16h16 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) to the securities class action pending in the United...